These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30412674)

  • 1. Incurred sample reproducibility in pharmacokinetic bioanalysis: pros and cons from a CRO perspective.
    Timmons BM; Hay L; Gorman J; Stouffer B
    Bioanalysis; 2018 Nov; 10(21):1715-1717. PubMed ID: 30412674
    [No Abstract]   [Full Text] [Related]  

  • 2. Incurred sample reanalysis: 'too much of a good thing?'.
    Fluhler EN
    Bioanalysis; 2018 Nov; 10(21):1719-1721. PubMed ID: 30301361
    [No Abstract]   [Full Text] [Related]  

  • 3. Incurred sample reproducibility: 10 years of experiences: views and recommendations from the European Bioanalysis Forum.
    Kall MA; Michi M; van der Strate B; Freisleben A; Stoellner D; Timmerman P
    Bioanalysis; 2018 Nov; 10(21):1723-1732. PubMed ID: 30412676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of incurred sample reanalysis: failures, investigations and impact.
    Lee LB; Wickremsinhe ER
    Bioanalysis; 2018 Nov; 10(21):1767-1772. PubMed ID: 30301360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A look back at the incurred sample reanalysis.
    Vazvaei F
    Bioanalysis; 2018 Nov; 10(21):1711-1713. PubMed ID: 30412679
    [No Abstract]   [Full Text] [Related]  

  • 6. Incurred sample reanalysis in AstraZeneca small molecule portfolio - what have we learned and where do we go next?
    Arfvidsson C; Wilson A; Heijer M; Bailey C; Severin P; Milligan F; Ngeny M; Dayton B; Li Y; Cape S
    Bioanalysis; 2018 Nov; 10(21):1733-1745. PubMed ID: 30325197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incurred sample reanalysis at GSK: what have we learned?
    Summerfield SG; Barfield M; White SA
    Bioanalysis; 2018 Nov; 10(21):1755-1766. PubMed ID: 30325209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incurred sample reproducibility: what have we learned and how can we build on our learnings?
    Timmerman P
    Bioanalysis; 2018 Nov; 10(21):1707-1709. PubMed ID: 30421622
    [No Abstract]   [Full Text] [Related]  

  • 9. ISR: what have we learned after a decade of experience?
    Verhaeghe T
    Bioanalysis; 2018 Nov; 10(21):1747-1753. PubMed ID: 30301364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incurred sample reproducibility.
    Vazvaei F; Timmerman P
    Bioanalysis; 2018 Nov; 10(21):1705-1706. PubMed ID: 30810353
    [No Abstract]   [Full Text] [Related]  

  • 11. Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?
    Rudzki PJ; Biecek P; Kaza M
    AAPS J; 2019 Feb; 21(2):28. PubMed ID: 30746568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product Development.
    Obianom ON; Thway TM; Schrieber SJ; Okusanya OO; Wang YM; Huang SM; Zineh I
    AAPS J; 2019 Sep; 21(6):105. PubMed ID: 31512109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
    Huang Y; Shi R; Gee W; Bonderud R
    Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
    Bower J; Fast D; Garofolo F; Gouty D; Hayes R; Lowes S; Nicholson R; LeLacheur R; Bravo J; Shoup R; Dumont I; Carbone M; Zimmer J; Ortuno J; Caturla MC; Datin J; Lansing T; Fatmi S; Struwe P; Sheldon C; Islam R; Yu M; Hulse J; Kamerud J; Lin J; Doughty J; Kurylak K; Tang D; Buonarati M; Blanchette A; Levesque A; Gagnon-Carignan S; Lin J; Ray G; Liu Y; Khan M; Xu A; El-Sulayman G; DiMarco C; Bouhajib M; Tacey D; Jenkins R; der Strate Bv; Briscoe C; Karnik S; Rhyne P; Garofolo W; Schultz G; Roberts A; Redrup M; DuBey I; Conliffe P; Pekol T; Hantash J; Cojocaru L; Allen M; Reuschel S; Watson A; Farrell C; Groeber E; Malone M; Nowatzke W; Fang X
    Bioanalysis; 2014; 6(22):2957-63. PubMed ID: 25496252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
    Timmerman P; Luedtke S; van Amsterdam P; Brudny-Kloeppel M; Lausecker B; Fischmann S; Globig S; Sennbro CJ; Jansat JM; Mulder H; Thomas E; Knutsson M; Kasel D; White SA; Kall MA; Mokrzycki-Issartel N; Freisleben A; Romero F; Andersen MP; Knebel N; de Zwart M; Laakso S; Hucker RS; Schmidt D; Gordon B; Abbott R; Boulanger P
    Bioanalysis; 2009 Sep; 1(6):1049-56. PubMed ID: 21083073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover.
    Lowes S; Jersey J; Shoup R; Garofolo F; Needham S; Couerbe P; Lansing T; Bhatti M; Sheldon C; Hayes R; Islam R; Lin Z; Garofolo W; Moussallie M; Teixeira Lde S; Rocha T; Jardieu P; Truog J; Lin J; Lundberg R; Breau A; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Jenkins R; Nicholson R; Lin MH; Karnik S; DeMaio W; Smith K; Cojocaru L; Allen M; Fatmi S; Sayyarpour F; Malone M; Fang X
    Bioanalysis; 2012 Apr; 4(7):763-8. PubMed ID: 22512795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?
    Kaza M; Karaźniewicz-Łada M; Kosicka K; Siemiątkowska A; Rudzki PJ
    J Pharm Biomed Anal; 2019 Feb; 165():381-385. PubMed ID: 30590335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development.
    Thway TM; Wang YM; Booth BP; Maxfield K; Huang SM; Zineh I
    AAPS J; 2019 Dec; 22(1):15. PubMed ID: 31858313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical considerations for assessment of bioanalytical incurred sample reproducibility.
    Hoffman D
    AAPS J; 2009 Sep; 11(3):570-80. PubMed ID: 19669410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.